Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2006
11/09/2006WO2006118267A1 Anthranylamide compound, process for producing the same and pest control agent containing the compound
11/09/2006WO2006117677A1 Androgen modulators
11/09/2006WO2006117669A1 Amide resorcinol compounds
11/09/2006WO2006117549A1 Enzyme inhibitors
11/09/2006US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006US20060252813 Apparatus for curing a composite laminate
11/09/2006US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006US20060252751 specific compound N-(2-{[(3R)-1-(4-hydroxy-4-pyrimidin-4-ylcyclohexyl)pyrrolidin-3-yl]amino}-2-oxoethyl)-3-(trifluoromethyl)benzamide; multiple sclerosis; CCR2 and/or CCR5 antagonists
11/09/2006DE10315276B4 Vinylpyrrolidon-(Co-)Polymer Vinylpyrrolidone (co) polymer
11/09/2006CA2607506A1 Novel lactam compound
11/09/2006CA2605985A1 Amide resorcinol compounds
11/09/2006CA2599411A1 Enzyme inhibitors
11/08/2006EP1719757A1 Bicyclo derivative
11/08/2006EP1719529A1 Contrast medium for thrombus formation
11/08/2006EP1718639A2 Caspase inhibitors and uses thereof
11/08/2006EP1718633A1 N-type calcium channel blockers
11/08/2006EP1718626A1 Sulfonylpyrrolodine modulators of androgen receptor fuction and method
11/08/2006EP1718621A2 Nitroxyl progenitor compounds and methods of use
11/08/2006EP1718610A1 Pyrrole-3-carboxamide derivatives for the treatment of obesity
11/08/2006EP1718307A2 Immunosuppressant compounds and compositions
11/08/2006EP1718292A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation disorders
11/08/2006EP1296716B1 Use of a beta-blocker for the treatment of atherosclerosis
11/08/2006CN1859914A Phenyl pyrrolidine ether tachykinin receptor antagonists
11/08/2006CN1859904A Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
11/08/2006CN1283625C Purified LASOFOXIFENE and a method for purification of racemic LASOFOXIFENE by recrystallization
11/07/2006US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006US7132567 Composition for use in the adhesion of particle to surfaces
11/07/2006US7132552 Reacting aminobutanamide hydrochloride with chlorobutyl chloride in solvent such as acetonitrile and methyl tert-butyl ether in base
11/07/2006US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome
11/07/2006US7132543 Para-phenylenediamine derivatives containing a disubstituted pyrrolidinyl group bearing a cationic radical, and use of the same for dyeing keratin fibers
11/07/2006US7132534 Para-phenylenediamine derivatives containing a pyrrolidyl group, and use of these derivatives for coloring keratin fibers
11/07/2006US7132518 Mono- and bis-hydrazone pigments
11/07/2006US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/07/2006US7132444 Process for the preparation of trans-3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl) amino]carbonyl]amino]sulfonyl] phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide
11/07/2006US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006US7132442 6H-thieno[2, 3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH)
11/07/2006US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006US7132422 An aromatic-oxy-alkyleneamine derivative, useful for treating neuropathic pain
11/07/2006US7132420 Aspartic protease inhibitors
11/07/2006US7132295 Isotopically coded affinity markers 3
11/07/2006US7132269 Coupling agents, the active intermediates and the conjugates thereof and the use of said conjugates in diagnostic methods
11/07/2006US7132001 Oxidative dye couplers; light, wash and rub fastness; storage stability; intense shades
11/07/2006CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
11/02/2006WO2006116157A2 Dipeptidyl peptidase-iv inhibitors
11/02/2006WO2006074873A3 New one-step synthesis of useful disubstituted amines
11/02/2006WO2006069808A3 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
11/02/2006WO2006061215A3 2-alkyl-cycloalk(en)yl-carboxamides
11/02/2006US20060247444 Process for making 5-methyl-N-alkyl-2-pyrrolidone from alkyl amine(s) and levulinic acid
11/02/2006US20060247443 Process for making 5-methyl -N-alkyl-2-pyrrolidone from alkyl amines and alkyl levulinate esters
11/02/2006US20060247300 Aminocyclohexyl ether compounds and uses thereof
11/02/2006US20060247289 Certain chemical entities, compositions, and methods
11/02/2006US20060247260 Bis (hetero) aryl carboxamide derivatives for use as PG12 antagonists
11/02/2006US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006EP1717225A1 Bicyclic amide derivatives
11/02/2006EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006EP1716134A1 Amino heterocyclic modulators of chemokine receptor activity
11/02/2006EP1716120A1 Herbicidal heteroaroyl-substituted phenylalanine amides
11/02/2006EP1716115A2 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
11/02/2006EP1716114A1 Process for preparing amorphous atorvastatin hemi-calcium by dissolving the salt in an organic solvent which is a mixture of an alcohol and a ketone and/or an ester and removing the solvent
11/02/2006EP1716100A2 Therapeutic amide derivatives
11/02/2006EP1716088A1 Catalytic asymmetric synthesis of optically active alpha-halo-car bonyl compounds
11/02/2006EP1716087A1 Process for c-c coupling between electrophilic substrates and pi-nucleophiles in neutral to basic acqueous or alcoholic solvents without the use of a lewis or proteic acid.
11/02/2006EP1715920A1 Cathepsin cysteine protease inhibitors
11/02/2006EP1715892A2 Methods and compositions for modulating angiogenesis
11/02/2006EP1377278B1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
11/02/2006EP1360176B1 Pyrrolecarboxamides for use as fungicides
11/02/2006EP1339685B1 Biphenylcarboxamides useful as lipid lowering agents
11/02/2006EP1214295B1 Hydroxyacetamidobenzenesulphonamide derivatives
11/02/2006EP1127045B1 Triphenylbutene derivatives for the treatment of neurological disorders
11/02/2006CA2604603A1 Novel cyclic amines
11/02/2006CA2604531A1 Vla-4 antagonists
11/02/2006CA2599419A1 Dipeptidyl peptidase-iv inhibitors
11/01/2006CN1856461A Cycloalkylidene compounds as modulators of estrogen receptor
11/01/2006CN1854129A Superhigh purity ionic liquid
11/01/2006CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/01/2006CN1282643C Intermediate for preparing compounds having serotonin-2 receptor antagonistic and alpha-1 blocking action and its preparing method
11/01/2006CN1282640C N-arylphenylacetamide derivatives and medicinal compositions containing same
10/2006
10/31/2006US7129376 Method for the production of a purified melt of at least one monomer
10/31/2006US7129362 Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive of levulinic acid esters with aryl and alkyl amines
10/31/2006US7129266 its production by fermentation, to methods for its recovery and concentration from the crude solutions, and to a process for its purification
10/31/2006US7129260 Isoindolinone kinase inhibitors
10/31/2006US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor
10/31/2006US7129233 Competitive and selective inhibitors of trypsin-like serine proteases involved in hemostasis; anticoagulants; e.g., 1-((1-haloalkoxy)phenyl)-),2-(hydroxy),ethyl)carbonyl-),2-((4-amidinopyrid-1-yl)methaminocarbonyl)pyrrole
10/31/2006CA2262906C Novel immunotherapeutic agents and their use in the reduction of cytokine levels
10/31/2006CA2214670C 2-cyano-3, 5-dihydroxyhex-2-enecarboxamide derivatives
10/26/2006WO2006113274A1 Biodegradable polyphosphazenes containing pyrrolidone side groups
10/26/2006WO2006112778A1 New muscarinic receptor antagonists
10/26/2006WO2005113534A3 Cxcr1 and cxcr2 chemokine antagonists
10/26/2006US20060241259 for photopolymerization; photography, relief imaging; color filters
10/26/2006US20060241169 Crystalline forms of [R-(R*.R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
10/26/2006US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis
10/26/2006US20060241110 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
10/26/2006DE19860843B4 Bis(dialkylmaleimid)-Derivat und daraus hergestelltes Polyetherimid für die optische Nachrichtentechnik (Nachrichtenübertragung) Bis (dialkylmaleimid) derivative and produced therefrom polyetherimide for optical communications technology (communication)
10/25/2006EP1714958A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
10/25/2006EP1713823A2 Hcv ns-3 serine protease inhibitors
10/25/2006EP1713822A2 Hcv ns-3 serine protease inhibitors
10/25/2006EP1401824B1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
10/25/2006EP1301520B8 Ligands, complex compounds and their use for polymerising olefins